Resumen
The expansion of the donor lung pool has involved an evidence-driven redefinition of acceptable donors. Proceeding with transplantation with an acceptable rather than ideal donor depends on specific patient-related and organ-related risk factors as well as the severity of recipient illness. Although the physiologic optimization of brain-dead donors has not changed significantly in recent years, the use of donor management protocols has improved procurement rates. Ex vivo lung perfusion is an increasingly viable strategy to recondition lungs that would otherwise fall below the acceptable threshold for transplant. Ex vivo perfusion trials for preservation of standard donor lungs are ongoing.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 751-759 |
| Número de páginas | 9 |
| Publicación | Clinics in Chest Medicine |
| Volumen | 38 |
| N.º | 4 |
| DOI | |
| Estado | Published - dic 2017 |
Nota bibliográfica
Publisher Copyright:© 2017 Elsevier Inc.
Financiación
| Financiadores | Número del financiador |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | K23HL116656 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Huella
Profundice en los temas de investigación de 'Evaluation and Management of the Potential Lung Donor'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver